- CA$12.13m
- CA$21.34m
- CA$11.17m
- 45
- 52
- 44
- 44
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.15 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -34.93% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 3.07 | 6.11 | 11.42 | 10.46 | 11.17 | 14.3 | 18.5 | 49.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Newtopia Inc. is a Canada-based technology-enabled habit change company that delivers disease prevention solutions by leveraging genetic testing, social and behavioral science to help individuals prevent chronic disease and reduce costs for health insurers. As a provider of whole-person care, it prevents, reverses and slows the progression of chronic disease while enriching mental health, resilience and overall human performance. The Company’s programs leverage genetic, social, and behavioral insights to create individualized prevention programs with a focus on type two diabetes, heart disease, stroke, metabolic disease, mental health challenges, hypertension, weight management and musculoskeletal disorders. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, the Company delivers sustainable clinical and financial outcomes. Its personalized habit change platform focuses on physical and mental health risk reduction.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- May 9th, 2008
- Public Since
- May 4th, 2020
- No. of Employees
- 100
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
TSX Venture Exchange- Shares in Issue
- 173,265,303
- Address
- 33 Bloor Street East, 5th Floor, TORONTO, M4W 3H1
- Web
- https://www.newtopia.com/
- Phone
- +1 4162230212
- Auditors
- MNP LLP
Upcoming Events for NEWU
Q2 2024 Newtopia Inc Earnings Release
Similar to NEWU
ARCpoint
TSX Venture Exchange
Cannara Biotech
TSX Venture Exchange
Element Lifestyle Retirement
TSX Venture Exchange
Hempshire
TSX Venture Exchange
Jack Nathan Medical
TSX Venture Exchange
FAQ
What is the Newtopia share price?
As of Today at 19:15 UTC, shares in Newtopia are trading at CA$0.07. This share price information is delayed by 15 minutes.
How has the Newtopia share price performed this year?
Shares in Newtopia last closed at CA$0.07 and the price had moved by -22.22% over the past 365 days. In terms of relative price strength the Newtopia share price has underperformed the Toronto Stock Exchange 300 Composite Index by -26.2% over the past year.
What are the analyst and broker recommendations for Newtopia?
The overall consensus recommendation for Newtopia is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Newtopia dividend yield?
Newtopia does not currently pay a dividend.
Does Newtopia pay a dividend?
Newtopia does not currently pay a dividend.
When does Newtopia next pay dividends?
Newtopia does not currently pay a dividend.
How do I buy Newtopia shares?
To buy shares in Newtopia you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Newtopia?
As of the previous close price of CA$0.07, shares in Newtopia had a market capitalisation of CA$12.13m.
Where are Newtopia shares listed?
Here are the trading details for Newtopia:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: NEWU
What kind of share is Newtopia?
Based on an overall assessment of its quality, value and momentum Newtopia is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Newtopia share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Newtopia share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Newtopia. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -35.64%.
As of the last closing price of CA$0.07, shares in Newtopia were trading -15.76% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Newtopia PE Ratio?
The Newtopia PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.07.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Newtopia?
Newtopia's management team is headed by:
- Jeffrey Ruby - CEO
- Anthony Lam - CFO
- Mark Jackson - SVP
- Bill Wyck - CTO
- Natasha Vani - OTH
- Roger Poirier - DRC